CD40LG and aspergillosis: An IgM monoclonal antibody targeting catalase B exhibited antifungal activity in vitro, while a novel conjugate of an A. fumigatus-specific IgM monoclonal antibody with alliinase significantly improved survival in immunosuppressed mice with pulmonary aspergillosis.